Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-18 4:11 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Cormorant Asset Management LP | 2,025,000 19.3% | 2,025,000 (New Position) | View |
| 2024-02-28 4:38 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | MILLENNIUM MANAGEMENT LLC | 544,276 5.3% | 544,276 (New Position) | View |
| 2024-02-14 4:45 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | K2 HealthVentures Equity Trust LLC | 342,113 7.5% | 342,113 (New Position) | View |
| 2024-02-14 4:41 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | K2 HealthVentures Equity Trust LLC | 10,524,401 7.8% | 10,524,401 (New Position) | View |
| 2024-02-14 4:08 pm Sale | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Paradigm Biocapital Advisors LP | 0 0% | -399,658 (Position Closed) | View |
| 2024-02-12 4:42 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | ADAGE CAPITAL PARTNERS GP L.L.C. | 796,392 7.7% | 796,392 (New Position) | View |
| 2024-02-12 4:18 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | RA CAPITAL MANAGEMENT L.P. | 430,182 4.1% | 430,182 (New Position) | View |
| 2024-02-09 4:11 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | INTEGRATED CORE STRATEGIES (US) LLC | 419,707 4.1% | 419,707 (New Position) | View |
| 2024-02-05 4:47 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Cormorant Global Healthcare Master Fund LP | 1,475,000 14.27% | 1,475,000 (New Position) | View |
| 2024-02-05 4:21 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Paradigm Biocapital Advisors LP | 399,658 9% | 399,658 (New Position) | View |
| 2024-01-29 4:40 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Point72 Asset Management L.P. | 388,676 8.8% | 388,676 (New Position) | View |
| 2024-01-26 4:28 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | TANG CAPITAL PARTNERS LP | 426,220 9.6% | 426,220 (New Position) | View |
| 2022-08-24 1:59 pm Sale | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | ETF MANAGERS GROUP LLC | 6,194,679 4.95% | -4,800,464 (-43.66%) | View |
| 2022-02-14 3:55 pm Sale | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | ETF MANAGERS GROUP LLC | 10,995,143 8.78% | -3,245,214 (-22.79%) | View |
| 2021-06-01 1:22 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | ETF MANAGERS GROUP LLC | 14,240,357 11.39% | 7,566,899 (+113.39%) | View |
| 2021-05-11 1:33 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | ETF MANAGERS GROUP LLC | 6,673,458 5.34% | 676,115 (+11.27%) | View |
| 2021-04-09 6:02 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | BlackRock Inc. BLK | 5,673,664 4.5% | 453,139 (+8.68%) | View |
| 2021-03-17 1:07 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | ETF MANAGERS GROUP LLC | 5,997,343 4.8% | 145,996 (+2.50%) | View |
| 2021-02-16 10:52 am Sale | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | ETF MANAGERS GROUP LLC | 5,851,347 6.96% | -1,944,819 (-24.95%) | View |
| 2021-02-12 1:19 pm Sale | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | ETF MANAGERS GROUP LLC | 7,796,166 9.28% | -1,139,481 (-12.75%) | View |